Go beyond the surface with Medicann Insights — a space where we share what drives us, how we support our patients, and why our approach to medical cannabis care sets us apart. Real insight. Real care. Real people.
Cannabis oil has shown potential to ease IBS symptoms, including abdominal pain, bloating, and digestive discomfort. By influencing gut inflammation and nervous system signaling, it may provide relief under the guidance of a medical professional.
Read More
Medical cannabis may help reduce the severity and frequency of migraines by interacting with the body’s endocannabinoid system to relieve pain and inflammation. Clinical evidence and patient experiences suggest it can be a complementary option for managing chronic migraine symptoms.
Read More
Medical cannabis is legal in the UK under strict regulations, and patients can access it through licensed clinics with a valid prescription. Understanding the legal framework helps patients safely navigate treatment options and ensures compliance with the law.
Read More
This week’s Medicinal Cannabis Matters reflects a growing maturity in the medicinal cannabis industry, both in the UK and across Europe. From clearer understanding of UK regulation, to formal medical education in cannabis medicine and long-awaited reimbursement framework in France, the conversation continues to shift towards patient-centred progress.
Read More
Cannabis may influence digestive function and potentially help relieve constipation by interacting with the endocannabinoid system. Patients should consult a medical professional to determine if cannabis is a safe and effective option for their digestive health needs.
Read More
Cannabis offers a range of medical benefits, including relief from chronic pain, inflammation, neurological conditions, and other health issues. Evidence continues to grow, highlighting its potential as a versatile treatment option when prescribed responsibly.
Read More